2EyesVision

Simulations of multifocal corrections before cataract and presbyopia surgery

2EyesVision is a company that specializes in developing and commercializing novel ophthalmic technologies. As a spin-off of the Spanish National Research Council (CSIC), we are driven to revolutionize the ophthalmic industry and solve current unmet patient needs through innovative products.

Our focus lies in addressing highly prevalent ocular conditions such as presbyopia, which affects nearly 100% of the population above 45 years old, and cataracts, whose prevalence is estimated to double with 230 million people affected by 2050. With the combined expertise of Dr. Carlos Dorronsoro (CEO) and Prof. Dr. Susana Marcos (co-inventor and promoter), internationally recognized scientists, we have developed the groundbreaking SimVis Gekko, a binocular visual simulator for an accurate and personalized experience of premium presbyopic and cataract corrections.

• Established company, with highly specialized and seasoned leadership team with balance of business, commercial, engineering, and scientific expertise in the ophthalmology sector
• International Presence in 18 countries across 4 continents with dedicated specialized resellers in 10 territories
• Validated technology by 25+ scientific publications and protected by 8 international patent families
• Regulatory clearance completed in Key Markets
• Specialized manufacturing area: demonstrated scalable factory based on manufacturing cells with ISO9001 certification.
• Strong relationships with top-notch key opinion leaders (KOLs).
• A Medical Advisory Board with 10 of the most influential ophthalmologists and optometrists worldwide.
• Agreements with private international investors.
• Launch of SimVis Gekko 2 in 2025, introducing significant technological enhancements and superior clinical workflow integration.